Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint.

C Carda1, G Silvestrini, M E Gomez de Ferraris

  • 1Department of Pathology, Medical School, University of Valencia, Av Blasco Ibañez 17, 46010 Valencia, Spain. carmen.carda@uv.es

Tissue & Cell
|May 19, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways.

Leukemia·2023
Same author

Computational model of articular cartilage regeneration induced by scaffold implantation in vivo.

Journal of theoretical biology·2022
Same author

The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia.

Frontiers in cell and developmental biology·2022
Same author

Bioactive potential of silica coatings and its effect on the adhesion of proteins to titanium implants.

Colloids and surfaces. B, Biointerfaces·2017
Same author

In vitro assessment of the biological response of Ti6Al4V implants coated with hydroxyapatite microdomains.

Journal of biomedical materials research. Part A·2016
Same author

Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.

Oral diseases·2016

Osteoprotegerin (OPG) and RANKL are key regulators of bone development in the fetal craniomandibular joint (CMJ). Their co-expression in bone cells suggests a coupled role in regulating bone metabolism during CMJ formation.

Area of Science:

  • Developmental biology
  • Skeletal biology
  • Craniomaxillofacial development

Background:

  • Craniomandibular joint (CMJ) bone formation involves intramembranous and endochondral ossification.
  • Osteoprotegerin (OPG) and Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) are critical regulators of osteoclastogenesis.

Purpose of the Study:

  • To investigate the localization of OPG and RANKL mRNA and protein within the developing fetal CMJ.
  • To elucidate the roles of OPG and RANKL in CMJ embryogenesis.

Main Methods:

  • Immunohistochemistry (IHC) was used to detect OPG and RANKL protein.
  • In situ hybridization (ISH) was employed to localize OPG and RANKL mRNA.
  • These techniques were applied to fetal CMJ tissue samples.

Related Experiment Videos

Main Results:

  • OPG and RANKL mRNA and protein were found to be co-localized in the same cell types, particularly osteogenic cells.
  • Immunolabeling was observed in hypertrophic chondrocytes, early osteocytes, periosteal osteoclasts, and chondroclasts.
  • Intense OPG and RANKL labeling was detected in the new bone matrix and trabecular borders.

Conclusions:

  • The co-expression of OPG and RANKL in CMJ bone cells supports their coordinated function in regulating bone metabolism.
  • Their presence in the extracellular matrix suggests a localized regulatory role in CMJ development.